In a Healio video perspective from the ASRS meeting, Dr. Danny Mammo discusses the impact of triamcinolone acetonide on intraocular pressure (IOP) in patients with uveitic macular edema. A retrospective review of 60 eyes showed that 70% of patients with a history of glaucoma or steroid response did not have a rise in IOP after one suprachoroidal injection of triamcinolone acetonide. This suggests that suprachoroidal steroid injection may be a safer alternative for high-risk patients with IOP issues and uveitic macular edema, although not completely safe. The study was presented at the ASRS annual meeting in 2024.
Source link
Triamcinolone acetonide an option in those with uveitic macular edema, IOP issues
